Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
17.60
-0.50 (-2.76%)
At close: Jul 21, 2026, 4:00 PM EDT
17.50
-0.10 (-0.57%)
After-hours: Jul 21, 2026, 4:27 PM EDT
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Tandem Diabetes Care stock has a consensus rating of "Buy" and an average price target of $28.43. The average 1-year stock price forecast is 61.53% higher than the current stock price, while the lowest is $15.5 (-11.93%) and the highest is $50 (+184.09%).
Price Target: $28.43 (+61.53%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 10 | 10 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 14 | 11 | 11 | 11 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 23 | 23 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Hold Maintains $24 → $20 | Hold | Maintains | $24 → $20 | +13.64% | Jul 15, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $21 → $16 | Hold | Maintains | $21 → $16 | -9.09% | Jul 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $30 | Buy | Maintains | $30 | +70.45% | Jul 14, 2026 |
| Citi | Citi | Hold Maintains $17 | Hold | Maintains | $17 | -3.41% | Jul 8, 2026 |
Kieran Ryan Deutsche Bank No rating | Deutsche Bank | Hold Initiates $16 | Hold | Initiates | $16 | -11.93% | Jun 23, 2026 |
Financial Forecast
Revenue This Year
1.08B
from 1.01B
Increased by 6.09%
Revenue Next Year
1.21B
from 1.08B
Increased by 12.07%
EPS This Year
-0.69
from -2.58
EPS Next Year
0.11
from -0.69
EPS and Forward PE are based on non-GAAP adjusted numbers.